Commercialization


  • Business people leaning over a table together analyzing charts and graphs.
    Image attribution tooltip
    Tinnakorn Jorruang via Getty Images
    Image attribution tooltip

    How pharma marketers can reclaim the drug pricing narrative

    As Medicare negotiations heat up, it’s more important than ever for pharma companies to communicate their value. Here’s how.

    By Sept. 28, 2023
  • Abstract header image of Phil Inc.
    Image attribution tooltip
    Permission granted by Phil Inc
    Image attribution tooltip
    Sponsored by Phil Inc

    Optimizing your hub services program with a gross-to-net lens

    In today’s Biopharma landscape, considering Gross-to-Net is essential for effectively designing and optimizing patient support programs.

    Sept. 25, 2023
  • Opioids, pills, syringe
    Image attribution tooltip
    iStock via Getty Images
    Image attribution tooltip
    Q&A

    As the opioid crisis seethes, a long-lasting treatment could offer new ammunition

    Launched this month, Brixadi from Braeburn gives patients a new tool to overcome addiction.

    By Sept. 21, 2023
  • Pharma five-year plan
    Image attribution tooltip
    iStock via Getty Images
    Image attribution tooltip

    Moderna’s bold five-year plan reflects Big Pharma tradition of ‘Will they deliver?’

    Forecasts from the biggest pharma companies follow a pattern of thinking big and manifesting the desired outcome.

    By Sept. 15, 2023
  • Actor Ice T puts hands up in the air.
    Image attribution tooltip
    Courtesy of Sanofi
    Image attribution tooltip

    O.G. Ice-T teams up with Sanofi in horror-themed flu vax ad

    The French pharma’s latest vaccine campaign aims to raise awareness about the flu’s complications for marginalized groups. 

    By Sept. 14, 2023
  • Close up of a machine with several tubes, some of which are red.
    Image attribution tooltip
    saengsuriya13 via Getty Images
    Image attribution tooltip
    Q&A

    In the renal space, innovation could tackle health disparities. But the system doesn’t reward it.

    Reimbursement challenges have created barriers for new dialysis products, according to the chief commercial officer of CorMedix.

    By Sept. 14, 2023
  • CSL Seqirus influenza vaccine being prepared in the lab.
    Image attribution tooltip
    Permission granted by CSL Seqirus
    Image attribution tooltip

    Finding the right flu vaccine is hard. Getting people to take it is harder.

    Experts have determined the strains of this year’s flu season — now the question is whether people are too fatigued by the pandemic to be immunized.

    By Aug. 30, 2023
  • A white pill bottle, pills and a measuring tap sit on a dish on top of a yellow table
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip

    Are weight loss drugs a win for the global economy?

    As Novo Nordisk’s drug Wegovy sways Denmark’s economy, we're examining wider implications for the weight loss market. 

    By Aug. 28, 2023
  • Henrietta Lacks
    Image attribution tooltip

    Steve Ruark/AP

    Image attribution tooltip

    Henrietta Lacks’ immortal cells put biopharma profits under a microscope

    The HeLa cell line’s contributions to medical science were obtained without permission, and now biotechs profiting from its use are answering for it.

    By Aug. 23, 2023
  • Lonely sailing yacht in the ocean at the approaching storm and raining clouds at sunrise
    Image attribution tooltip
    Arsen Volkov via Getty Images
    Image attribution tooltip

    Behind Flagship Pioneering’s triumphs and tribulations

    From the rise of Moderna to the fall of Kaleido, here's a look at the VC fund's biggest successes and failures to date.

    By Aug. 18, 2023
  • Boxes of the diabetes drug Ozempic rest on a pharmacy counter on April 17, 2023 in Los Angeles, California.
    Image attribution tooltip
    Mario Tama / Getty via Getty Images
    Image attribution tooltip

    Demand for weight loss drugs soars to nearly half of Americans

    Drugs like the buzzy Ozempic are high on consumers’ radar — but lofty barriers to access remain.

    By Alexandra Pecci • Aug. 15, 2023
  • Christy Siegel WoW
    Image attribution tooltip
    Permission granted by Novartis
    Image attribution tooltip
    Podcast

    Woman of the Week: Novartis’ Christy Siegel

    The oncology portfolio general manager for breast and women’s cancers, discusses the company’s recent “landmark” trial and how her family’s history connects her to patients.

    By Taren Grom and Meagan Parrish • Aug. 15, 2023
  • drug pricing protest
    Image attribution tooltip
    Anna Moneymaker via Getty Images
    Image attribution tooltip

    PBMs could soon feel the regulatory sting

    From Congress to the FTC to state legislatures, regulators are cracking the whip against PBMs.

    By Aug. 4, 2023
  • Headshot of Afaxys CEO and co-founder Ronda Dean
    Image attribution tooltip
    Permission granted by Afaxys
    Image attribution tooltip
    Profile

    Putting purpose over profits, this pharma takes on the important issues

    Afaxys is a self-described "socially conscious" contraceptive healthcare company serving an unusual demographic for pharma: the public health sector.

    By Alexandra Pecci • Aug. 1, 2023
  • A reflection of the Twitter logo cast on a phone screen emblazoned with the Threads logo
    Image attribution tooltip
    Justin Sullivan/Staff via Getty Images
    Image attribution tooltip

    Threads joins the social media fray. Here’s what it means for pharma marketers.

    Meta’s new platform is drawing Twitter comparisons and could hold potential for pharma marketers in patient and HCP communication.

    By July 18, 2023
  • Stethoscope , passport document, airplane and globe on a table.
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip
    Q&A // First 90 Days

    A BMS exec’s journey around the world in 90 days

    As BMS grapples with upcoming patent cliffs, Emma Charles, the new SVP of intercontinental markets, is focused on expanding its footprint.

    By July 5, 2023
  • Abbey Jenkins Gamida Cell
    Image attribution tooltip
    Permission granted by Abbey Jenkins Gamida Cell
    Image attribution tooltip
    Podcast

    Woman of the Week: Gamida Cell’s Abbey Jenkins

    The first-time CEO discusses the lessons she has learned since taking the role last year and how she’s pivoting the company into a commercial entity.

    By June 14, 2023
  • lightbulb pill
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip
    Q&A

    Ranking reveals biopharma’s most innovative companies

    IDEA Pharma’s 12th index finds that Pfizer and AstraZeneca reign supreme again.

    By June 7, 2023
  • Christy Shafer Marinus
    Image attribution tooltip
    Permission granted by Marinus Pharmaceuticals
    Image attribution tooltip
    Podcast

    Woman of the Week: Marinus Pharmaceuticals’ Christy Shafer

    The chief commercial officer shares how the company “beat the odds” to bring a rare disease drug to market.

    By June 7, 2023
  • pills rising
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip
    Opinion

    A key to ‘winning’ in today’s market — and other trends pharma leaders are tracking

    Healthcare pros share the market drivers they believe are having the biggest impact on the industry.

    By June 2, 2023
  • Laurie Stelzer Mirati
    Image attribution tooltip
    Permission granted by Laurie Stelzer Mirati
    Image attribution tooltip
    Podcast

    Woman of the Week: Mirati Therapeutics’ Laurie Stelzer

    With the recent approval of Krazati, the biotech veteran is guiding Mirati into its next phase as a commercial organization.

    By May 31, 2023
  • An illustration of a globe with large multicolored pins pointing to countries.
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip

    Taking your biotech global? Here’s how you can navigate cultural norms

    What’s so different about doing pharma business in the U.K. versus Japan? One of Moderna’s top brass shares her tips for navigating choppy cultural waters.

    By Alexandra Pecci • May 2, 2023
  • Peyton Howell Parexel
    Image attribution tooltip
    Permission granted by Peyton Howell
    Image attribution tooltip
    Q&A

    5 minutes with — Parexel’s Peyton Howell

    The company’s chief operating and growth officer on her personal quirks and why every pharma leader should read "Getting Naked."

    By April 7, 2023
  • A scientist with protective eyeglasses and mask holding a red transparent pill with fingers in gloves in the pharmaceutical research laboratory
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip

    A drug just launched for a disease discovered only 10 years ago

    Pharming just landed an FDA approval for a treatment targeting an ultra-rare immunodeficiency disorder discovered only a decade ago — and it’s already in the hands of patients.

    By April 6, 2023
  • A TV remote points up at a blurred-out screen.
    Image attribution tooltip
    simpson33 via Getty Images
    Image attribution tooltip

    Cutting the cord — why streaming is a new frontier for pharma advertising

    As streaming services proliferate, and more TV watchers buy in, there’s a new world of possibilities for DTC pharma marketing.

    By March 27, 2023